110 related articles for article (PubMed ID: 2930575)
1. Specific alterations in the biological activities of C-20'-modified vinblastine congeners.
Borman LS; Kuehne ME
Biochem Pharmacol; 1989 Mar; 38(5):715-24. PubMed ID: 2930575
[TBL] [Abstract][Full Text] [Related]
2. Single site-modified congeners of vinblastine dissociate its various anti-microtubule actions.
Borman LS; Kuehne ME; Matson PA; Marko I; Zebovitz TC
J Biol Chem; 1988 May; 263(15):6945-8. PubMed ID: 3366760
[TBL] [Abstract][Full Text] [Related]
3. Action of the vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide on microtubules in vitro.
Himes RH; Kersey RN; Heller-Bettinger I; Samson FE
Cancer Res; 1976 Oct; 36(10):3798-802. PubMed ID: 954003
[TBL] [Abstract][Full Text] [Related]
4. Immunofluorescence study of the action of navelbine, vincristine and vinblastine on mitotic and axonal microtubules.
Binet S; Chaineau E; Fellous A; Lataste H; Krikorian A; Couzinier JP; Meininger V
Int J Cancer; 1990 Aug; 46(2):262-6. PubMed ID: 2200754
[TBL] [Abstract][Full Text] [Related]
5. Modulation of drug cytotoxicity in wild-type and multidrug-resistant tumor cells by stereoisomeric series of C-20'-vinblastine congeners that lack antimicrotubule activity.
Borman LS; Bornmann WG; Kuehne ME
Cancer Chemother Pharmacol; 1993; 31(5):343-9. PubMed ID: 8431967
[TBL] [Abstract][Full Text] [Related]
6. Vinca alkaloid-induced tubulin spiral formation correlates with cytotoxicity in the leukemic L1210 cell line.
Lobert S; Fahy J; Hill BT; Duflos A; Etievant C; Correia JJ
Biochemistry; 2000 Oct; 39(39):12053-62. PubMed ID: 11009620
[TBL] [Abstract][Full Text] [Related]
7. Microtubule-disrupting effects of gallium chloride in vitro.
Perchellet EM; Ladesich JB; Collery P; Perchellet JP
Anticancer Drugs; 1999 Jun; 10(5):477-88. PubMed ID: 10477168
[TBL] [Abstract][Full Text] [Related]
8. Multiple microtubule alterations are associated with Vinca alkaloid resistance in human leukemia cells.
Kavallaris M; Tait AS; Walsh BJ; He L; Horwitz SB; Norris MD; Haber M
Cancer Res; 2001 Aug; 61(15):5803-9. PubMed ID: 11479219
[TBL] [Abstract][Full Text] [Related]
9. Kinetic analysis of tubulin exchange at microtubule ends at low vinblastine concentrations.
Jordan MA; Wilson L
Biochemistry; 1990 Mar; 29(11):2730-9. PubMed ID: 2346745
[TBL] [Abstract][Full Text] [Related]
10. Biochemical effects of Navelbine on tubulin and associated proteins.
Fellous A; Ohayon R; Vacassin T; Binet S; Lataste H; Krikorian A; Couzinier JP; Meininger V
Semin Oncol; 1989 Apr; 16(2 Suppl 4):9-14. PubMed ID: 2496470
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of mitotic block and inhibition of cell proliferation by the semisynthetic Vinca alkaloids vinorelbine and its newer derivative vinflunine.
Ngan VK; Bellman K; Hill BT; Wilson L; Jordan MA
Mol Pharmacol; 2001 Jul; 60(1):225-32. PubMed ID: 11408618
[TBL] [Abstract][Full Text] [Related]
12. Spongistatin 1, a highly cytotoxic, sponge-derived, marine natural product that inhibits mitosis, microtubule assembly, and the binding of vinblastine to tubulin.
Bai R; Cichacz ZA; Herald CL; Pettit GR; Hamel E
Mol Pharmacol; 1993 Oct; 44(4):757-66. PubMed ID: 8232226
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of vinblastine, vincristine, vindesine, and vinepidine on microtubule dynamics and cell proliferation in vitro.
Jordan MA; Himes RH; Wilson L
Cancer Res; 1985 Jun; 45(6):2741-7. PubMed ID: 3986806
[TBL] [Abstract][Full Text] [Related]
14. Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid.
Kruczynski A; Barret JM; Etiévant C; Colpaert F; Fahy J; Hill BT
Biochem Pharmacol; 1998 Mar; 55(5):635-48. PubMed ID: 9515574
[TBL] [Abstract][Full Text] [Related]
15. Interaction of vinca alkaloids with tubulin: a comparison of vinblastine, vincristine, and vinorelbine.
Lobert S; Vulevic B; Correia JJ
Biochemistry; 1996 May; 35(21):6806-14. PubMed ID: 8639632
[TBL] [Abstract][Full Text] [Related]
16. Vinflunine, a new vinca alkaloid: cytotoxicity, cellular accumulation and action on the interphasic and mitotic microtubule cytoskeleton of PtK2 cells.
Jean-Decoster C; Brichese L; Barret JM; Tollon Y; Kruczynski A; Hill BT; Wright M
Anticancer Drugs; 1999 Jul; 10(6):537-43. PubMed ID: 10885901
[TBL] [Abstract][Full Text] [Related]
17. Vinblastine, Vincristine and Vindesine: anti-invasive effect on MO4 mouse fibrosarcoma cells in vitro.
Mareel MM; Storme GA; De Bruyne GK; Van Cauwenberge RM
Eur J Cancer Clin Oncol; 1982 Feb; 18(2):199-210. PubMed ID: 7201395
[TBL] [Abstract][Full Text] [Related]
18. Vinblastine-induced aggregation of brine shrimp (Artemia) tubulin.
Mackinlay SA; Ludueña RF; MacRae TH
Biochim Biophys Acta; 1986 Jul; 882(3):419-26. PubMed ID: 3730421
[TBL] [Abstract][Full Text] [Related]
19. Additivity of dilantin and vinblastine inhibitory effects on microtubule assembly.
Lobert S; Ingram JW; Correia JJ
Cancer Res; 1999 Oct; 59(19):4816-22. PubMed ID: 10519390
[TBL] [Abstract][Full Text] [Related]
20. Indirubin, a bis-indole alkaloid binds to tubulin and exhibits antimitotic activity against HeLa cells in synergism with vinblastine.
Mohan L; Raghav D; Ashraf SM; Sebastian J; Rathinasamy K
Biomed Pharmacother; 2018 Sep; 105():506-517. PubMed ID: 29883946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
